MEOBF: Mesoblast Limited Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 1,072.88
Enterprise Value ($M) 1,153.83
Book Value ($M) 461.26
Book Value / Share 0.36
Price / Book 2.33
NCAV ($M) -122.38
NCAV / Share -0.10
Price / NCAV -8.77

Profitability (mra)
Return on Invested Capital (ROIC) -0.18
Return on Assets (ROA) -0.15
Return on Equity (ROE) -0.22

Liquidity (mrq)
Quick Ratio 0.63
Current Ratio 0.96

Balance Sheet (mrq) ($M)
Current Assets 69.68
Assets 653.32
Liabilities 192.06
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
MDIN – MedGen, Inc. MDRM – Modern Mobility Aids, Inc.
MEHCQ – 23andMe Holding Co. MITPF – Mithra Pharmaceuticals SA
MIXX – Mix1 Life, Inc.


Financial data and stock pages provided by
Fintel.io